Medication info

Korea Magnesium Sulfate Injection 10%

Prescription medicationInjectionsIntramuscular injection · Intravenous injection
Ingredient · strength
Magnesium Sulfate Hydrate›0.1g / 1mL
Manufacturer / importer
Daehan Pharmaceutical Co., Ltd.
Appearance
Colorless, transparent liquid filled in a colorless transparent glass ampoule or plastic aqueous injection container
Packaging
50 ampoules/box[(10mL/ampoule)], 50 ampoules/box[(20mL/ampoule)]
Approval status
Active

MFDS item code 200100339 · Notified 2001.05.07 · Insurance code 645101091

Summary

Main use
Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity
Who receives it
Adults · Children
Adult administration
○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Administer 4 ∼ 5 g of this medication intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Initially administer 4 g of this medication intravenously (16.2 mmol). An additional 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this medication intramuscularly every 6 hours for 4 doses. Alternatively, add 5 g of this medication to 5 % dextrose injection or 0.9 % sodium chloride injection and administer intravenously over 3 hours. During treatment of the deficiency, closely monitor the patient's renal excretory function.
Child administration
○ Children: The safety of this medication has not been studied.

Ingredients

Manufacturer
Daehan Pharmaceutical Co., Ltd.

Efficacy & effects

Electrolyte supplementation; suppression of convulsions and seizures (hypomagnesemia, eclampsia); prevention of uterine rigidity

  • Convulsions due to hypomagnesemia
  • seizures of eclampsia
  • uterine contractions
View approved original text

This medication is used to prevent and treat convulsions due to hypomagnesemia and seizures associated with eclampsia. It also helps prevent uterine contractions, aiding in safe pregnancy and delivery, and is effective for electrolyte replenishment in hypomagnesemia. Overall, it helps normalize the functions of the nervous system and muscles.

How it is given

Adult administration

○ Convulsions due to hypomagnesemia: Administer 1 ∼ 2 g of magnesium sulfate intravenously (4.05 ∼ 8.1 mmol). ○ Eclamptic seizures: Administer 4 ∼ 5 g of this medication intravenously over 10 minutes (16.2 ∼ 20.25 mmol) ○ Prevention of uterine rigidity: Initially administer 4 g of this medication intravenously (16.2 mmol). An additional 1 g may be administered. ○ Electrolyte replacement (hypomagnesemia): Administer 1 g of this medication intramuscularly every 6 hours for 4 doses. Alternatively, add 5 g of this medication to 5 % dextrose injection or 0.9 % sodium chloride injection and administer intravenously over 3 hours. During treatment of the deficiency, closely monitor the patient's renal excretory function.

Child administration

○ Children: The safety of this medication has not been studied.

Precautions

This medication is in a glass ampoule form, and glass particles may be mixed when opening the container, so it must be carefully cut during use. Particular caution is needed when administering to children or the elderly. This medication should not be given to patients with poor kidney function, comatose patients, patients with high magnesium levels in the blood, those with cardiac conduction disorders, and patients with myasthenia gravis. Caution is advised when administering to children with intestinal parasitic diseases and patients with heart conditions. Gastrointestinal side effects such as vomiting or dryness of the mouth may occur when using this medication. Additionally, circulatory issues such as cardiac arrhythmias or bradycardia may rarely arise. Rapid injection may cause reddening of the skin or peripheral blood vessel dilation. Autonomic nervous system symptoms such as headaches, a heavy sensation in the head, tremors, and tingling may occur. In case of overdose, symptoms may include fever, severe thirst, reduced blood pressure, suppression of the central nervous system and heart rate, leading to difficulties in breathing, necessitating caution. Calcium injections can be used for detoxification in such cases. A burning sensation may be felt at the injection site. The effects of this medication may be enhanced when used with other CNS depressants, so caution is advised. Using it with iron supplements, certain antibiotics, fluorinated compounds, etc., may decrease their absorption. When used with muscle relaxants, the effects of this medication may increase and affect muscle function. It may be administered to pregnant women for treating eclampsia, but it could affect the fetus with decreased muscle tone, hypotension, or respiratory depression, so fetal condition must be monitored carefully. It is best not to use this medication during labor or within 2 hours post-delivery. With prolonged or repeated doses, it is essential to monitor the calcium and magnesium levels in newborns and be aware of skeletal side effects. The safety during breastfeeding has not been established, so it is not recommended unless specifically necessary. Elderly patients may have reduced bodily functions, so administration should be done slowly, adjusting the dosage as needed. Severe problems with heart and respiration can arise in case of overdose, so symptoms should be closely monitored and treated immediately if needed. Intravenous injections should be administered slowly at a concentration of less than 10%, and it is advisable not to mix it with other medications, as precipitates may form. Before administration, ensure the patient's skin and injection equipment are thoroughly disinfected, and the medication should be used immediately after opening, with any leftover medication not to be reused.

Side effects

  • vomiting
  • dry mouth
  • conduction disorder
  • bradycardia
  • flushing
  • peripheral vasodilation
  • headache
  • heaviness in the head
  • tremor
  • tingling
Show 7 more
  • warmth
  • thirst
  • hypotension
  • central nervous system depression
  • heart rate suppression
  • respiratory paralysis
  • warmth at the injection site

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air, ideally between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness and prevents degradation.

Appearance and packaging

Appearance

Colorless, transparent liquid filled in a colorless transparent glass ampoule or plastic aqueous injection container

Package unit

50 ampoules/box[(10mL/ampoule)], 50 ampoules/box[(20mL/ampoule)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.